Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-16
2005-08-16
Fay, Zohreh (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S912000
Reexamination Certificate
active
06930127
ABSTRACT:
A composition and method for veterinary treatment of ophthalmic immune-mediated inflammatory conditions in animals such as conjunctival disorders of the third eyelid, keratoconjunctivitis sicca (KCS), chronic superficial keratitis (CSK), feline eosinophilic keratoconjunctivitis, allergic conjunctivitis, blepharoconjunctivitis, ocular rosacea, viral conjunctivitis, uveitis and phacoanaphylactic endophthalmitis involves the topical administration of tacrolimus to the eye in a pharmaceutically acceptable lubricant vehicle. The composition of the invention includes about 0.00001% to 10.0% tacrolimus by weight in a pharmaceutically acceptable oil-based solution or ointment and may be administered to the third eyelid of an affected animal.
REFERENCES:
patent: 4649047 (1987-03-01), Kaswan
patent: 4839342 (1989-06-01), Kaswan
patent: 5411952 (1995-05-01), Kaswan
patent: 5457182 (1995-10-01), Wiederrecht et al.
patent: 5624893 (1997-04-01), Yanni
patent: 6331313 (2001-12-01), Wong et al.
patent: 6489335 (2002-12-01), Peyman
patent: 2003/0212090 (2003-11-01), Chen et al.
E.D. Donnenfeld, MD, et al., Cyclosporine provides effective treatment for dry eye, Therapeutic Updates in Ophthalmology, Jul. 1999, pp. 1-3, Irvine, CA.
G.M. Lipper, MD, et al., Recent Therapeutic Advances in Dermatology, JAMA, Jan. 12, 2000, pp 175-177, vol. 283, No. 2, Chicago, IL.
Hampson, et al.; Ocular Discharge and Eyelid Swelling in a Cat; Aust. Vet. J., pp. 172, 185-186, vol. 79, No. 3, Mar. 2001; Brunswick, Vic. 3056.
Christine Dresser, DVM; New Treatment for Dry Eye; The Nova: Rising Star Issue, p. 21, Nov., 2002.
Eaton Veterinary Laboratories, Inc.
Fay Zohreh
Rodgers Marcia J.
Shughart Thomson & Kilroy P.C.
LandOfFree
Veterinary treatment of ophthalmic disease in animals using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Veterinary treatment of ophthalmic disease in animals using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Veterinary treatment of ophthalmic disease in animals using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3523719